Mobile

Intra-individual efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or limb arterial diseases

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-011002-42

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the clinical equivalence of the diagnostic performance of DOTAREM®-enhanced MRA as compared to GADOVIST® - enhanced MRA by comparing the arterial visualization of vessels from the abdominal aorta to pedal artery.

Critère d'inclusion

  • Patient suffering from Peripheral Arterial Occlusive Disease (PAOD) stage II or III

Liens